Director Eric Sachetta Adds $225K in Sensus Healthcare Stock, Extending Week-Long Buying Streak
SRTS sits 34% above its 52-week low of $2.66 on elevated volume (2.1× avg).
Summary
Director Eric Sachetta purchased $225,616 of Sensus Healthcare stock on August 28 and 31, extending a week-long insider buying streak that now totals over $500,000.
Key Events · Ownership and Investor Activity · SRTS
-
Director Buys $225K in Open Market
Eric Sachetta acquired 64,841 shares for $225,616 across two purchases on August 28 ($3.437/share) and August 31 ($3.538/share).
-
Week-Long Accumulation Streak
This filing brings Sachetta's total open-market purchases over the past week to approximately $503,000 across four separate Form 4 filings.
-
Insider Buying Despite Weak Q2
Purchases come two weeks after Q2 2026 revenue fell 68.5% to $2.29 million and net loss widened to $8.75 million, suggesting insider confidence in a turnaround.
-
CEO Also Buying
CEO Joseph Sardano bought $60,486 of stock on August 24, reinforcing the insider accumulation signal across multiple executives.
Analysis · SRTS · Industrial Applications And Services
Director Eric Sachetta bought another $225,616 of Sensus Healthcare stock across two open-market purchases on August 28 and August 31, bringing his total buying over the past week to roughly $503,000. This is his fourth Form 4 filing in eight days, and the purchases come just two weeks after the company reported a 68.5% revenue decline and an $8.75 million net loss for Q2 2026. A director putting this much personal capital to work at prices between $3.44 and $3.54 — near the stock's current level — is a notable show of conviction despite the deteriorating fundamentals. The accumulation pattern, combined with CEO Joseph Sardano's $60,486 purchase on August 24, suggests insiders see value at these levels even as the business faces significant headwinds.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 29.9% of the 1939 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SRTS was trading at $3.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $58.5M. The 52-week trading range was $2.66 to $5.49. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.